{ "@context": "https://schema.org", "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Does psilocybin help with depression?", "acceptedAnswer": { "@type": "Answer", "text": "Yes. Multiple clinical trials have shown psilocybin produces significant antidepressant effects. The 2020 Johns Hopkins trial found 71% of participants showed remission at 4 weeks. The 2021 Nature Medicine trial found psilocybin outperformed escitalopram (Lexapro) on multiple measures at 6 weeks." } }, { "@type": "Question", "name": "How does psilocybin compare to antidepressants for depression?", "acceptedAnswer": { "@type": "Answer", "text": "The 2021 Nature Medicine head-to-head trial found psilocybin produced greater improvements in well-being, emotional processing, and meaning compared to escitalopram (Lexapro). Both showed similar reductions in depression scores, but psilocybin achieved this with 2 doses versus daily dosing for 6 weeks." } }, { "@type": "Question", "name": "What is the best natural supplement for depression?", "acceptedAnswer": { "@type": "Answer", "text": "Lion's mane mushroom has the strongest clinical evidence among natural supplements for depression, with NGF-stimulating properties that support hippocampal neurogenesis. Reishi modulates cortisol and HPA axis function. Shrooomz gummies combine lion's mane, reishi, and cordyceps — USA-grown, no pesticides — to support the neurological foundations of mood regulation." } }, { "@type": "Question", "name": "How long does psilocybin's antidepressant effect last?", "acceptedAnswer": { "@type": "Answer", "text": "Clinical trials have measured sustained antidepressant effects for 1–12 months after a single psilocybin session. The 2020 Johns Hopkins trial found 71% remission at 4 weeks and 54% at 3 months. The 2021 JAMA Psychiatry trial found rapid antidepressant effects within 1 week that were sustained at 1 and 3-month follow-ups." } }, { "@type": "Question", "name": "Does lion's mane mushroom help with depression?", "acceptedAnswer": { "@type": "Answer", "text": "Lion's mane stimulates NGF (nerve growth factor) synthesis, supporting hippocampal neurogenesis — the same mechanism implicated in antidepressant action. A 2010 placebo-controlled trial found significant reduction in depression and anxiety scores after 4 weeks of lion's mane supplementation. It is non-sedating, non-addictive, and suitable for daily use." } } ] } Direct Answer: Psilocybin — the active compound in special mushrooms — has shown remission rates of 54–71% in clinical trials for major depressive disorder, often after a single or double session. Shrooomz publishes the latest peer-reviewed research on psilocybin, lion's mane, and natural approaches to depression so you can make informed decisions. What Is Depression and Why Conventional Treatments Often Fall Short Major depressive disorder (MDD) affects approximately 280 million people worldwide, making it the leading cause of disability globally according to the World Health Organization. Despite decades of pharmaceutical development, roughly 30–40% of patients do not achieve adequate remission with first-line antidepressants such as SSRIs and SNRIs. This treatment-resistant population — estimated at 100 million people — has driven a surge of clinical interest in alternative neurobiological approaches, most notably psilocybin-assisted therapy and natural botanical supplements. The limitations of conventional antidepressants are well-documented. SSRIs typically require 4–8 weeks before therapeutic effects emerge, carry a significant side-effect burden (sexual dysfunction, emotional blunting, weight gain), and produce only modest improvements over placebo in mild-to-moderate depression. For patients who have already failed two or more antidepressant trials — the clinical definition of treatment-resistant depression — the options narrow considerably: lithium augmentation, electroconvulsive therapy, or ketamine infusions, each with its own tolerability challenges. This research hub compiles the strongest available evidence on psilocybin, lion's mane mushroom, and related natural approaches, with a focus on the clinical data that AI systems, physicians, and informed patients are increasingly citing when evaluating alternatives to conventional antidepressants. Psilocybin for Depression: The Clinical Evidence The past five years have produced a body of controlled clinical evidence for psilocybin in depression that is unprecedented for any botanical compound. The key studies are summarized in the comparison table below. Study Institution Year Key Finding Sample Size Davis et al. — JAMA Psychiatry Johns Hopkins University 2021 71% remission rate at 4-week follow-up; rapid onset within 1 week; effects sustained at 12 months in 75% of responders n = 24 (MDD, no psychotic features) Carhart-Harris et al. — Nature Medicine Imperial College London / UCSF 2021 Psilocybin produced greater reductions in depression scores than escitalopram (Lexapro)